| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |